The government of India gave approval to four waitlisted firms under the production linked incentive (PLI) scheme for domestic manufacturing of bulk drugs.
Daily Current Affairs Quiz 2021
The department of pharmaceuticals had launched the PLI scheme for promotion of domestic manufacturing of critical bulk drugs – Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs).
It envisages setting up greenfield plants in four different target segments with a total outlay of Rs 6,940 crore for the period 2020-21 to 2029-30.
Setting up of these plants will make the country self-reliant to a large extent in respect of these Bulk drugs. The disbursal of production linked incentive by the Government over the six years period would be up to a maximum of about Rs.6,000 cr.
